28 April 2021

In a recent article in Nature Communications, researchers from the department of Medical Microbiology uncovered intriguing dynamics in the production of the transmission stages of malaria parasites, gametocytes.

Children with incident malaria infections and children with chronic infections were followed on a daily basis to determine what proportion of parasites commit to become gametocyte. With novel molecular markers developed by Kjerstin Lanke, they could for the very first time quantify gametocyte commitment as well as the subsequent release of male and female gametocytes into the circulation.

Using these novel assays, the work demonstrated that the early phase of malaria infections is characterized by a low commitment to gametocyte production. The sparse gametocytes that are produced are hardly infectious to mosquitoes and this infectivity is further decreased if mosquitoes ingest gametocytes at a moment of fever. In contrast, chronic infections produce more gametocytes that are often clonally complex and highly infectious gametocytes. This work underlines the importance of early infection detection to not only prevent severe illness but also prevent transmission of infections to the community.

The work was led by Aïssata Barry, a PhD student from Burkina Faso in the team of Teun Bousema, for whom the work is a concluding chapter of her thesis.​View article in Nature Communications. 

Aïssata Barry and Teun Bousema celebrating their paper in Ouagadougou.

Related news items

KNAW Early Career Award for Martine Hoogman

2 December 2021

Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.

read more

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab

1 December 2021

Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro.

read more

Participating in cancer research among people with intellectual disabilities

30 November 2021

Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer.

read more

Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

read more